Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 0.2696
-0.0082 (-2.95%)
Aug 1, 2025, 5:29 PM CET
Chimerix Market Cap
Xbrane Biopharma AB has a market cap or net worth of 413.08 million as of August 1, 2025. Its market cap has increased by 17.68% in one year.
Market Cap
413.08M
Enterprise Value
537.97M
Revenue
277.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.27
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 413.08M, an increase of 215.20%. That is a compound annual growth rate of 12.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 425.64M | 73.07% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | 1.66B | 211.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Feb 3, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 102.35B |
| Sectra AB | 69.48B |
| Getinge AB | 53.56B |
| Asker Healthcare Group AB | 50.26B |
| Medicover AB | 43.03B |
| Camurus AB | 42.78B |
| Bonesupport Holding AB | 22.39B |
| AddLife AB | 21.08B |